COMMUNIQUÉS West-GlobeNewswire

-
Sienna Senior Living Inc. Reports Strong Fourth Quarter 2023 Financial Results and Delivers 16.5% Increase in Same Property Net Operating Income
21/02/2024 -
Sanofi: Information concerning the total number of voting rights and shares - January 2024
20/02/2024 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Janvier 2024
20/02/2024 -
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
20/02/2024 -
Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024
20/02/2024 -
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
20/02/2024 -
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
20/02/2024 -
DBV Technologies participera au prochain congrès de l’AAAAI 2024
20/02/2024 -
Viemed Healthcare Announces Date and Time for Conference Call
20/02/2024 -
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
20/02/2024 -
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
20/02/2024 -
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024
20/02/2024 -
Arvinas Announces Chief Financial Officer Transition
20/02/2024 -
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
20/02/2024 -
PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital Market
20/02/2024 -
CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/02/2024 -
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
20/02/2024 -
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
20/02/2024 -
NurExone’s Intellectual Property Portfolio Expands
20/02/2024
Pages